Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients.

[1]  D. Schaffer,et al.  Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  H. Büning,et al.  Adeno-associated Vector Toxicity-To Be or Not to Be? , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  Jessica Zucman-Rossi,et al.  Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas , 2015, Nature Genetics.

[4]  David Hurlbut,et al.  Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  A. Elkahloun,et al.  Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. , 2015, The Journal of clinical investigation.

[6]  R. Heilbronn,et al.  Adeno-Associated Virus Type 2 Wild-Type and Vector-Mediated Genomic Integration Profiles of Human Diploid Fibroblasts Analyzed by Third-Generation PacBio DNA Sequencing , 2014, Journal of Virology.

[7]  C. von Kalle,et al.  Linear amplification mediated PCR--localization of genetic elements and characterization of unknown flanking DNA. , 2014, Journal of visualized experiments : JoVE.

[8]  C. von Kalle,et al.  Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyria. , 2013, Human gene therapy.

[9]  Stephan Wolf,et al.  A largely random AAV integration profile after LPLD gene therapy , 2013, Nature Medicine.

[10]  F. Bushman,et al.  Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction. , 2013, Human gene therapy.

[11]  K. L. La Perle,et al.  Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Pei-Rong Wang,et al.  Induction of hepatocellular carcinoma by in vivo gene targeting , 2012, Proceedings of the National Academy of Sciences.

[13]  Karine Tremblay,et al.  Efficacy and long term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open label trial , 2012, Gene Therapy.

[14]  Pratima Chowdary,et al.  Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. , 2011, The New England journal of medicine.

[15]  Namshin Kim,et al.  Methodology and software to detect viral integration site hot-spots , 2011, BMC Bioinformatics.

[16]  Hojun Li,et al.  Assessing the potential for AAV vector genotoxicity in a murine model. , 2011, Blood.

[17]  Shoshannah L. Roth,et al.  A method to sequence and quantify DNA integration for monitoring outcome in gene therapy , 2011, Nucleic acids research.

[18]  V. Haurigot,et al.  Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Jean Bennett,et al.  Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  Kathleen A. Marshall,et al.  Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[21]  Hanno Glimm,et al.  High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR) , 2007, Nature Methods.

[22]  Theresa A. Storm,et al.  DNA Palindromes with a Modest Arm Length of ≳20 Base Pairs Are a Significant Target for Recombinant Adeno-Associated Virus Vector Integration in the Liver, Muscles, and Heart in Mice , 2007, Journal of Virology.

[23]  Daniel G. Miller,et al.  AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma , 2007, Science.

[24]  C. von Kalle,et al.  Real-Time Definition of Non-Randomness in the Distribution of Genomic Events , 2007, PloS one.

[25]  E. Furth,et al.  Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  Brian T Luke,et al.  Redefining the common insertion site. , 2006, Virology.

[27]  Daniel G. Miller,et al.  Large-Scale Analysis of Adeno-Associated Virus Vector Integration Sites in Normal Human Cells , 2005, Journal of Virology.

[28]  Theresa A. Storm,et al.  Large-Scale Molecular Characterization of Adeno-Associated Virus Vector Integration in Mouse Liver , 2005, Journal of Virology.

[29]  R. Samulski,et al.  Integration of adeno-associated virus (AAV) and recombinant AAV vectors. , 2004, Annual review of genetics.

[30]  Daniel G. Miller,et al.  Adeno-associated virus vectors integrate at chromosome breakage sites , 2004, Nature Genetics.

[31]  Daniel G. Miller,et al.  Human Gene Targeting by Adeno-Associated Virus Vectors Is Enhanced by DNA Double-Strand Breaks , 2003, Molecular and Cellular Biology.

[32]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[33]  A. Gibbs,et al.  The Diagram, a Method for Comparing Sequences , 1970 .

[34]  Manfred Schmidt,et al.  Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  B. Fehse,et al.  Retroviral integration site analysis in hematopoietic stem cells. , 2008, Methods in molecular biology.

[36]  Theresa A. Storm,et al.  DNA palindromes with a modest arm length of greater, similar 20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart in mice. , 2007, Journal of virology.

[37]  A. Gibbs,et al.  The diagram, a method for comparing sequences. Its use with amino acid and nucleotide sequences. , 1970, European journal of biochemistry.